Sign in

CIK 0001684693 · Non-accelerated filer

Sol-Gel Technologies Ltd.

Sign in to watch
Ticker
SLGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
other
Phone
97289313433
Business address
7 GOLDA MEIR ST., WEIZMANN SCIENCE PARK, NESS ZIONA, Israel, 7403648
  1. 6-K Event Report of Foreign Issuer
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 4 Open-market buy 10% owner bought 3,124 shares at an average $66.39 ($207,399)
  8. 4 Open-market buy 10% owner bought 9,976 shares at an average $68.88 ($687,160)
  9. 4 Open-market buy 10% owner bought 1,683 shares at an average $69.21 ($116,488)
  10. 4 Open-market buy 10% owner bought 40,330 shares at an average $69.19 ($2,790,326)
  11. 6-K Event Report of Foreign Issuer
  12. 4 Open-market buy 10% owner bought 951 shares at $71.50 ($67,997)
  13. 4 Open-market buy 10% owner bought 1,695 shares at an average $73.64 ($124,819)
  14. 4 Open-market buy 10% owner bought 529 shares at an average $73.80 ($39,042)
  15. 4 Open-market buy 10% owner bought 1,712 shares at an average $71.97 ($123,220)
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 6-K Event Report of Foreign Issuer
  18. 4 Open-market buy 10% owner bought 1,563 shares at $64.43 ($100,712)
  19. 4 Open-market buy 10% owner bought 3,437 shares at an average $67.36 ($231,502)
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 1 of 17 · 331 filings